Praziquantel

Y. Vivian Tsai, Pharm.D., Paul G. Auwaerter, M.D.

INDICATIONS

FDA

  • FDA-approved in patients aged ≥1 year:
    Schistosomiasis caused by all Schistosoma species
    Clonorchiasis caused by Clonorchis sinensis
    • Opisthorchiasis caused by Opisthorchis viverrini

NON-FDA APPROVED USES

  • Cestode (Tapeworm) infections
    • Diphyllobothriasis (Diphyllobothrium latus)
      • Diphyllobothriid tapeworm infection, including Dibothriocephalus latus—formerly Diphyllobothrium latum.
    • Dipylidiasis (Dipylidium caninum)
    • Echinococcosis (Echinococcus spp.)
      • Cystic echinococcosis: occasionally used as a specialist-directed adjunct before surgery or following cyst-content spillage; not standard monotherapy.
    • Hymenolepiasis (Hymenolepis nana)
    • Neurocysticercosis (Taenia solium) as combination therapy with albendazole for patients with >2 viable parenchymal cysts.[14][16][6]
    • Taeniasis (Taenia solium, Taenia saginata)
  • Trematode (Fluke) infections
    • Fasciolopsiasis (Fasciolopsis buski)
    • Heterophyiasis (Heterophyes heterophyes)
    • Metagonimiasis (Metagonimus yokogawai)
    • Nanophyetiasis (Nanophyetus salmincola)
    • Paragonimiasis (Paragonimus westermani)

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: August 9, 2026